Patrick M Boland Selected Research

Patrick M Boland Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 07/2013
12	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 10/2014
7	Adenocarcinoma 12/2021 - 12/2017
4	Disease Progression 01/2023 - 01/2021
3	Microsatellite Instability 01/2023 - 01/2020
3	Rectal Neoplasms (Rectal Cancer) 03/2019 - 10/2014
2	Fatigue 04/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 08/2017 - 07/2013
2	Esophageal Neoplasms (Esophageal Cancer) 08/2017 - 07/2013
1	Embolism (Embolus) 04/2024
1	Asthenia 04/2024
1	Dehydration (Water Stress) 04/2024
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Iron Deficiencies 04/2022
1	Neutropenia 12/2021
1	Diarrhea 12/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2020
1	Colitis 04/2020
1	Pancreatitis 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2018
1	Pathologic Complete Response 12/2017
1	Turcot syndrome 05/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2015

Drug/Important Bio-Agent (IBA)

6	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2017
4	Immune Checkpoint InhibitorsIBA 01/2023 - 05/2017
4	pembrolizumabIBA 01/2023 - 01/2020
3	Capecitabine (Xeloda)FDA Link 04/2024 - 12/2021
2	Bevacizumab (Avastin)FDA Link 04/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2013
2	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 01/2022 - 01/2017
2	SurvivinIBA 01/2022 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2013
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2015
1	nintedanibIBA 04/2024
1	Tyrosine Kinase InhibitorsIBA 04/2024
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024
1	IronIBA 04/2022
1	Ferritins (Ferritin)IBA 04/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	atezolizumabIBA 01/2022
1	LigandsIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 12/2021
1	Gemcitabine FDA Link 12/2021
1	Monoclonal AntibodiesIBA 01/2021
1	CTLA-4 AntigenIBA 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	regorafenibIBA 01/2019
1	vandetanib (ZD6474)IBA 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2017
1	Carboplatin (JM8)FDA LinkGeneric 08/2017
1	CamptothecinIBA 01/2017
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017
1	human ERBB2 proteinIBA 07/2013

Therapy/Procedure

11	Therapeutics 01/2023 - 07/2013
5	Immunotherapy 01/2023 - 05/2017
4	Drug Therapy (Chemotherapy) 01/2024 - 08/2017
4	Neoadjuvant Therapy 12/2021 - 10/2014
3	Adjuvant Chemotherapy 01/2024 - 10/2014
2	Radiotherapy 01/2023 - 08/2017
1	Ovariectomy (Oophorectomy) 12/2021
1	Chemoradiotherapy 12/2021
1	Fecal Microbiota Transplantation 04/2020
1	Biological Therapy 04/2020
1	Transplantation 04/2020